Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
681,58 USD | -1,68 % |
|
-2,20 % | -4,32 % |
16/01 | REGENERON PHARMACEUTICALS, INC. : UBS da una recomendación neutral | ZM |
14/01 | Yancopoulos, CSO de Regeneron, habla de los fármacos para perder peso y de la cartera de productos en desarrollo | MT |
Grupo Regeneron Pharmaceuticals, Inc. : Gráfico Relacional
Empresas privadas pertenecientes al mismo grupo que REGENERON PHARMACEUTICALS, INC.
Empresa | Director |
---|---|
Regeneron Ireland DAC
![]() Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | - |
![Estados Unidos](/images/png-country/24x24/us.png)
MarketScreener is also available in this country: United States.
Switch edition